T issues are exposed to hypoxia followed by reoxygenation during ischemia-reperfusion, which occurs in several clinical settings, including organ transplantation, percutaneous coronary intervention, and bypass grafting.
Despite these insights, the mechanisms for NF-κB activation by hypoxia are understood incompletely and may vary according to particular cell types.
We previously discovered a regulator of NF-κB called Cezanne (Cellular Zinc-finger Anti-NF-κB; also known as OTUD7B) and cloned full-length cDNA from endothelial cells (ECs).
14 Our subsequent studies revealed that Cezanne can be induced by tumor necrosis factor α (TNFα), interleukin-1, and functions as an inhibitor of NF-κB, thus forming a negative feedback loop in inflammatory cytokine signaling, 15, 16 and a recent report indicated that Cezanne can also influence noncanonical NF-κB activation. 17 The molecular mechanism for the anti-inflammatory effects of Cezanne was recently illuminated by our group who demonstrated that this molecule belongs to a novel family of deubiquitinating enzymes. 18 Thus, Cezanne suppresses activation of NF-κB in response to TNFα by cleaving polyubiquitin chains from receptor interacting protein 1, which is a component of the tumor necrosis factor receptor complex. 15, 16 Cezanne is related to a protein called A20 (tumor necrosis factor alpha-induced protein 3), which can also suppress NF-κB activation via deubiquitination of signaling proteins. 19, 20 However, although A20 and Cezanne possess partially overlapping biochemical properties, they exert unique functions by targeting distinct forms of polyubiquitin. 20, 21 Here, we examined whether Cezanne can influence inflammatory responses to hypoxia-reoxygenation in ECs using both in vitro and in vivo models.
Methods

Reagents and Antibodies
Anti-Cezanne (Proteintech Europe Ltd), Anti-RelA (p65), anti-IκBα, anti-TRAF6, anti-Lamin B (Santa Cruz Biotechnology), phosphorylated anti-activating transcription factor 2 (anti-ATF2; Thr71), phosphorylated anti-RelA (Ser536; Cell Signaling Technology), antiubiquitin (Invitrogen), anti-Lys63 polyubiquitin, anti-GAPDH (Merck-Millipore), antiα-tubulin (Sigma-Aldrich), anti-kidney injury marker-1 (R&D Systems), and polyclonal goat anti-rabbit and antimouse conjugated horse radish peroxidise (Dako) antibodies were obtained commercially. Rabbit anti-Cezanne polyclonal antibodies were raised and subsequently affinity purified, as described previously. 15 Pharmacological inhibitors of p38 (CT8730, UCB Celltech & SB202190, Merck Chemical) and actinomycin D (Sigma-Aldrich) were obtained commercially and dissolved in dimethyl sulfoxide.
Endothelial Cells and Exposure to Hypoxia
Human coronary microvascular ECs and human dermal microvascular ECs were obtained commercially (Promocell). Human umbilical vein ECs (HUVECs) were collected using collagenase. ECs were cultured as described previously. 15 Confluent HUVEC cultures were exposed to 1% to 5% O 2 using the Ruskinn Hypoxia Workstation before reoxygenation (20% O 2 ; normoxia) as described previously. 9 Hypoxia is defined as exposure of cells to 1% O 2 unless stated otherwise.
RNA Interference
Cell cultures were transfected with small interfering RNA (siRNA) sequences that are known to silence Cezanne (5′-GAAUCUAUCU GCCUUUGGA-3′; Dharmacon 14 or SMARTpool ON-TARGETplus Human Otud7b siRNA), ATF2 (Dharmacon or SMARTpool ONTARGETplus Human ATF2 siRNA) or p38α (Dharmacon) using the Neon transfection system (Life Technologies) and were then incubated in antibiotic-free growth medium for 48 hours before analysis. Alternatively, they were transfected with nontargeting scrambled controls (Silencer Negative control # 1 siRNA; Ambion). To control for the possible effects of mRNA processing, cells were transfected with siRNA targeting Src homology 2-containing protein tyrosine phosphatase (Dharmacon), which is unlikely to be involved in TRAF signaling.
Comparative Real-Time Polymerase Chain Reaction
RNA was extracted using the EZNA Total RNA Kit I (Omega Bio-tek) and reverse transcribed into cDNA using qScript cDNA Supermix (Quanta Biosciences). Transcript levels were quantified by comparative real-time polymerase chain reaction (PCR) using gene-specific primers for human Cezanne (sense, 5′-ACAATGTCCGATTGGCCAGT-3′; antisense, 5′-ACAGTGGGAT CCACTTCACATTC-3′), human E-selectin (sense, 5′-GCTCTGC AGCTCGGACAT-3′; antisense, 5′-GAAAGTCCAGCTACCAAGG GAAT-3′), human VCAM-1 (sense, 5′-GGTGGGACACAAATA AGGGTTTTGG -3′; antisense, 5′-CTTGCAATTCTTTTACAGCC TGCC-3′), human intercellular adhesion molecule-1 (sense, 5′-GTC CCCTCAAAAGTCATCC-3′; antisense, 5′-AACCCCATTCAGCGT CACCT-3′), human β-actin (sense, 5′-CTGGAACGGTGAAGG TGACA-3′; antisense, 5′-AAGGGACTTCCTGTAACAATGCA-3′), murine VCAM-1 (sense, 5′-GTCAAAGAGGGAGACACCGT-3′; antisense, 5′-CGAGCCATCCACAGACTTTA-3′), murine E-selectin (sense, 5′-TTCGTGTACCAATGCATCCT-3′; antisense, 5′-GGCTT CCATAGTCAGGGTGT-3′), murine β-actin (sense, 5′-AGCGCA AGTACTCTGTGTGG-3′; antisense, 5′-CTTGCTGATCCACATCT GCT-3′), rat/murine Cezanne (sense, 5′-GGTTGGCAGCAGTTCTA TCA-3′; antisense, 5′-CAAAGCTGCCCAGTTTGTTA-3′), and rat β-actin (sense, 5′-AGCGCAAGTACTCTGTGTGG-3′; antisense, 5′-CTTGCTGATCCACATCTGCT-3′) using PerfeCTa SYBR Green Supermix (Quanta Biosciences) and the CFX96 Real-Time PCR Detection System (BioRad). Reactions were performed in triplicate. Relative gene expression was calculated by comparing the number of thermal cycles that were necessary to generate threshold amounts of product. Data were pooled from 3 independent experiments, and mean values were calculated with SDs.
Western Blotting
Levels of particular proteins were measured in cytosolic or nuclear lysates prepared using the Nuclear Extraction Kit (Active Motif) by Western blotting using specific primary antibodies, horseradish peroxidise-conjugated secondary antibodies, and chemiluminescent detection.
Immunoprecipitation of TRAF6
Cells were lysed using 30 mmol/L Tris-HCl (pH 7.6), 120 mmol/L NaCl, 1% Triton X-100, 2 mmol/L KCl, 2 mmol/L EDTA, 10% glycerol, and Complete Protease Inhibitor Cocktails (Roche). Lysates were clarified by low-speed centrifugation and precleared using protein-G-sepharose before immunoprecipitation using anti-TRAF6 antibodies. Beads were then washed extensively using lysis buffer. Precipitated material or lysates were analyzed by Western blotting.
Animals
Male Fisher rats (F344, RT1 lvl ; 170-210 g) were obtained commercially (Charles River, Sulzfeld, Germany). Transgenic gene-trapped (GT) mice, 22 in which the Cezanne gene is disrupted by removal of exons 4 to 7 and insertion of a splice acceptor site, LacZ open reading frame, neomycin resistance gene (Neo), and polyA tail in the third intron (B6-Otud7btm1(NCOM)Cmhd; Cezanne GT/GT ; C57BL/6 background) were obtained from the Canadian Mouse Mutant Repository. Splicing of the LacZ-Neo-polyA sequences to the third exon of Cezanne was confirmed by reverse transcriptase PCR (Online Figure I) and is predicted to generate a fusion protein comprising the peptide MTLDMDAVLSDFVRSTGAEPGLARDLLE (encoded by exon 3 of Cezanne) linked to LacZ. Baseline phenotyping analysis performed at the Toronto Center for Phenogenomics as part of the North American Conditional Mouse Mutagenesis Project revealed that Cezanne GT/GT mice are normal in terms of gross appearance, histopathology of multiple tissues, weight gain, glucose tolerance, and clinical chemistry (http://www.europhenome.org).
Renal Ischemia/Reperfusion
For the induction of renal ischemia/reperfusion in rats, the abdomen was opened under inhalation anesthesia using isofluorane. The left renal artery was clamped with an atraumatic vascular clamp for 45 minutes. During this time, the right kidney was removed. The left kidney was reperfused for 2 to 72 hours. Renal ischemia/ reperfusion in mice was performed under inhalation anesthesia using isofluorane. In wild-type and Cezanne GT/GT mice, the left renal artery was clamped with an atraumatic vascular clamp for 45 minutes and subsequently reperfused for 6 hours. Ischemia and subsequent reperfusion were confirmed at a macroscopic level by monitoring changes in tissue appearance. Principles of NIH Guide for the Care and Use of Laboratory Animals as well as the German Law on the Protection of Animals and UK Home Office regulations were followed.
Immunohistochemistry and Morphological Studies
Sections made from formalin-fixed, paraffin-embedded tissues were incubated in xylene for 5 minutes, hydrated by sequential exposure to decreasing concentrations of ethanol (100% to 50%) and water. Heatmediated antigen retrieval was performed in tris-sodium citrate in a A and B, Human umbilical vein ECs (HUVECs) were exposed to hypoxia (4 hours) or hypoxia followed by reoxygenation (1-24 hours) or remained untreated. A, Cezanne transcript levels were quantified by real-time polymerase chain reaction (PCR). Data were pooled from 3 independent experiments. B, Cytosolic lysates were tested by Western blotting using anti-Cezanne antibodies and by using anti-α-tubulin antibodies to assess total protein levels. Representative blots (top) and results from densitometry analysis of 5 experiments (bottom) are shown. C, Human dermal microvascular ECs (HDMECs) or human coronary microvascular ECs (HCMECs) were exposed to hypoxia (4 hours) or remained untreated. Cezanne transcript levels were quantified by real-time PCR. Data were pooled from 3 independent experiments. D, HUVECs or HCMECs were exposed to 1%, 2%, 5%, or normoxia (21%) for 4 hours. Cezanne transcript levels were quantified by real-time PCR. Data were pooled from 3 independent experiments. E and F, HUVECs were exposed to CT8730 (1 μmol/L) or SB202190 (50 μmol/L) for 1 hour or were treated with vehicle alone and then exposed to hypoxia (4 hours) or remained untreated. E, Cezanne transcript levels were quantified by realtime PCR. F, Cytosolic lysates were tested by Western blotting using antiCezanne antibodies and by using antiα-tubulin antibodies to assess total protein levels. ns indicates nonspecific band. G, HUVECs were treated with p38α-specific small interfering RNA (si-p38) or with a scrambled, nontargeting sequence and were then exposed to hypoxia (4 hours) or hypoxia (4 hours) followed by reoxygenation (4 hours) or remained untreated (normoxia). Cezanne transcript levels were quantified by real-time PCR.
standard microwave. The sections were then blocked for endogenous peroxidase activity and incubated in 20% goat serum before overnight incubation with primary antibodies followed by horseradish peroxidise-conjugated secondary antibodies and substrate (EnVision+Kits; Dako). Sections were then counterstained with hematoxylin and visualized by bright field microscopy. For morphological studies, sections were stained with hematoxylin and eosin before histological assessment. Tissue injury was assessed independently by 2 experienced renal researchers and classified as healthy or mild/moderate/severe injury, as we described. 9 Granulocytes were identified by staining using the napthol AS-D chloroacetate esterase kit (Sigma).
Statistics
Differences between samples were analyzed using an unpaired Student t test or ANOVA (*P<0.05, **P<0.01, ***P<0.001).
Results
Hypoxia Induces Cezanne via Transcriptional and Posttranscriptional Mechanisms
Studies of cultured HUVECs revealed that Cezanne mRNA and protein levels were enhanced by exposure to 1% O 2 and remained elevated for ≥24 hours after reoxygenation ( Figure 1A  and 1B ). This level of hypoxia (1% O 2 ) also induced Cezanne in cultured microvascular ECs at both the mRNA ( Figure 1C ) and protein levels (Online Figure II) . By contrast, exposure of ECs to 2% or 5% O 2 had little or no effect on Cezanne expression in HUVECs or human coronary microvascular ECs ( Figure 1D ). Thus, cellular responses to hypoxia were studied using 1% O 2 conditions in all subsequent experiments.
We studied the molecular mechanism for Cezanne induction and focused on the role of p38 mitogen-activated protein kinase and the transcription factor HIF1α, which are known to be activated by hypoxia. 8, 23, 24 Activation of HIF1α in response to dimethyloxallyl glycine, desferrioxamine, or CoCl 2 did not influence Cezanne expression (Online Figure  III) , and silencing of HIF1α or HIF2α did not suppress Cezanne expression in hypoxic ECs (Online Figure IV) , indicating that induction of Cezanne by hypoxia is HIF independent. By contrast, pharmacological inhibition of p38 using either CT8730 or SB202190 ( Figure 1E and 1F) or gene silencing of p38α ( Figure 1G ) suppressed the induction of Cezanne by hypoxia, indicating that p38 positively regulates Cezanne expression. We examined the mechanism of Cezanne induction by p38, which is known to influence gene expression via members of the ATF family and also by enhancing mRNA stability. 25 We observed that ATF2 was phosphorylated in response to hypoxia in both HUVECs and microvascular ECs (Figure 2A ). Thus, gene silencing studies were performed to assess the function of ATF2 in hypoxic ECs. We observed that silencing of ATF2 using 2 different siRNA sequences suppressed the induction of Cezanne by hypoxia ( Figure 2B ). By contrast, transfection using nontargeting scrambled sequences or using sequences that target an irrelevant mRNA (Src homology 2-containing protein tyrosine phosphatase) demonstrated that transfection and mRNA processing, per se, did not alter Cezanne induction by hypoxia ( Figure 2B ). Finally, Cezanne expression was reduced by 2 different siRNAs designed to target Cezanne, thus, validating the quantitative real-time PCR readout ( Figure 2B ). Thus, we conclude that ATF2 positively regulates Cezanne expression in hypoxic ECs. p38 also enhanced the stability of Cezanne transcripts in hypoxic ECs because pharmacological inhibition of p38 using SB202190 destabilized Cezanne mRNA in actinomycin D chase experiments (Online Figure 
V). Thus, we conclude that p38 induces Cezanne through both transcriptional and post-transcriptional mechanisms.
Cezanne Suppresses Inflammatory Activation in Response to Hypoxia-Reoxygenation by Inhibiting RelA Phosphorylation
We used a previously validated RNA interference method 15 ( Figure 2B ) to examine whether Cezanne regulates proinflammatory responses to hypoxia-reoxygenation. Silencing of Cezanne in HUVECs had no effect on basal levels of E-selectin or VCAM-1 in unstimulated cells ( Figure 3A , compare 1 and 2) but enhanced their subsequent induction by hypoxia-reoxygenation (compare 5 and 6, and 7 and 8). By contrast, silencing of Cezanne enhanced the expression of intercellular adhesion molecule-1 in ECs exposed to normoxia or hypoxia-reoxygenation ( Figure 3A, bottom) . Silencing of Cezanne using a pool of siRNA sequences from an alternative source also significantly enhanced the induction of E-selectin, VCAM-1, and intercellular adhesion molecule-1 in ECs exposed to hypoxia-reoxygenation (Online Figure VI) .
Because E-selectin, VCAM-1, and intercellular adhesion molecule-1 are induced by NF-κB, we examined whether Cezanne influences the activation of this transcription factor in response to hypoxia. Exposure of ECs to hypoxia-reoxygenation enhanced Ser536 phosphorylation of RelA NF-κB subunits but did not influence IκBα stability or nuclear localization of NF-κB ( Figure 3B ). Thus, hypoxia-reoxygenation activates NF-κB in ECs through a noncanonical pathway that involves RelA phosphorylation. Although silencing of Cezanne led to a modest reduction in IκBα expression ( Figure 3B, top) , the biological significance is questionable because there was no noticeable effect of Cezanne siRNA on NF-κB nuclear localization ( Figure 3B, bottom) . By contrast, silencing of Cezanne led to a pronounced elevation in Ser536 phosphorylation of RelA in cells exposed to hypoxia-reoxygenation ( Figure 3B , middle), indicating that endogenous Cezanne negatively regulates NF-κB activation and proinflammatory transcriptional responses under these conditions.
Cezanne Prevents Lys63 Polyubiquitination of TRAF6 in Response to Hypoxia-Reoxygenation
We examined whether Cezanne influences Lys63-polyubiquitination of TRAF6, a modification that promotes NF-κB activation in response to hypoxia. 12 Analysis of TRAF6 immunoprecipitates revealed that hypoxia-reoxygenation induced high-molecular weight forms of TRAF6 that coprecipitated with Lys63-polyubiquitin in ECs that were pretreated with Cezanne-specific siRNA but not in control cultures ( Figure 4A , compare 4 and 9; Figure 4B , compare 3 and 6). Kinetic studies demonstrated that hypoxia-reoxygenation for 4 to 8 hours led to modification of TRAF6 in the absence of Cezanne, whereas earlier (2 hours) and later time points (16-24 hours) had little or no effect (Online Figure VII) . It is plausible that modification of TRAF6 requires ≥4 hours exposure to hypoxia attributable to the requirement of de novo synthesis of a component of the ubiquitination machinery. These data indicate that endogenous Cezanne suppresses TRAF6 polyubiquitination in response to hypoxia-reoxygenation.
Cezanne Reduces Inflammation and Injury in Response to Ischemia-Reperfusion
Our finding that Cezanne can be induced by hypoxia in vitro led us to examine the expression of Cezanne in tissues exposed to ischemia in vivo. We observed by quantitative reverse transcriptase PCR ( Figure 5A and 5C) and Western blotting ( Figure 5B ) that Cezanne was induced in rat or murine kidneys exposed to ischemia-reperfusion. Immunohistochemistry was performed to assess the cellular localization of Cezanne expression in ischemic tissues. This was performed exclusively using the murine model, so that tissues from Cezanne GT/GT mice could be used to control for staining specificity. Immunohistochemistry using anti-Cezanne antibodies revealed staining in vascular ECs, glomerular ECs, podocytes, and tubular epithelial cells in wild-type mice exposed to ischemia-reperfusion, whereas tissues from Cezanne GT/GT mice were negative ( Figure 5D ). Thus, we conclude that ischemia-reperfusion induces Cezanne in multiple cell types in the kidney, including ECs.
The influence of Cezanne on NF-κB activation, inflammation, and injury was assessed by comparing responses to ischemia-reperfusion in wild-type and Cezanne GT/GT mice. In the first instance, we demonstrated by quantitative reverse transcriptase PCR that Cezanne was expressed in several tissues in wild-type mice (highest in brain) but was absent from peripheral blood cells (Online Figure VIII) . Renal ischemia-reperfusion promoted the accumulation of granulocytes ( Figure 6A ) and enhanced tissue injury ( Figure 6B ; Online Figure IX ) in kidneys of wild-type mice. Of note, granulocyte accumulation and tissue injury in response to ischemia-reperfusion were significantly greater in Cezanne GT/GT mice compared with wild-type animals ( Figure 6 ; Online Figure IX) . Similarly, expression of VCAM-1 and E-selectin ( Figure 7A ) and Ser536 phosphorylation of RelA in response to ischemia-reperfusion were enhanced in Cezanne GT/GT mice compared with wild-type animals ( Figure 7B ). Thus, we conclude that ischemia induces local expression of Cezanne, which protects the kidney from NF-κB-dependent inflammation and injury in response to reperfusion.
Discussion
Recent studies have shown that the assembly of polyubiquitin chains on specific signaling intermediaries promotes signaling to NF-κB in response to several stimuli, including cytokines, microbial products, and hypoxia. 12, 26 Our previous studies revealed that Cezanne is a deubiquitinating enzyme that suppresses NF-κB activation in response to TNFα or interleukin-1 by removing polyubiquitin chains from signaling intermediaries. 15, 18 Here, we demonstrate that Cezanne can also inhibit NF-κB-dependent inflammatory activation in response to hypoxia-reoxygenation by reducing Lys63-polyubiquitination of TRAF6. To our knowledge, Cezanne is the first example of a deubiquitinating enzyme that controls inflammatory responses to hypoxia.
Inflammatory signaling activates multiple delayed negative feedback loops that precisely control the kinetics of NF-κB and mitogen-activated protein kinase activation. That is, NF-κB induces molecules that feedback to inhibit signaling to NF-κB (eg, IκBα, A20, Cezanne) 15, [27] [28] [29] and suppress the activity of inflammatory mitogen-activated protein kinases (eg, MKP-1, GADD45β). 30, 31 Here, we describe a novel form of cross-talk between the NF-κB and mitogen-activated protein kinase pathways, where p38-dependent induction of Cezanne during hypoxia suppresses NF-κB activity. Importantly, although hypoxia primed ECs for NF-κB activation, it simultaneously induced Cezanne, which blunted signaling to NF-κB during reoxygenation. Thus, hypoxia-reoxygenation had minimal effects on NF-κB activation and adhesion molecule expression in unmanipulated ECs but significantly enhanced inflammatory activation after silencing of Cezanne. This feed-forward inhibition pathway differs from typical delayed feedback systems because here the accelerator (signaling to NF-κB) and brake (Cezanne) are applied simultaneously. tumor necrosis factor receptor signaling provides a classic example of simultaneous activation of positive and negative regulators because it activates a proapoptotic pathway and simultaneously signals to NF-κB, which induces multiple antiapoptotic molecules. 32, 33 Thus, although TNFα can prime cells for apoptosis, the execution of TNFα-mediated apoptosis . Cezanne suppressed tumor necrosis factor receptor-associated factor 6 (TRAF6) polyubiquitination in response to hypoxiareoxygenation. Human umbilical vein ECs were treated with Cezanne-specific small interfering RNA (siRNA; si-Cezanne from Dharmacon) or with a scrambled, nontargeting sequence and were then exposed to hypoxia (4 hours) or hypoxia (4 hours) followed by reoxygenation (2-20 hours) or remained untreated. A, TRAF6 immunoprecipitates or lysates were tested by Western blotting using anti-TRAF6 antibodies. B, TRAF6 immunoprecipitates were tested by Western blotting using antibodies that recognize Lys63-polyubiquitin. ns indicates nonspecific. Data are representative of 3 independent experiments that gave closely similar results.
usually relies on additional factors that suppress NF-κB (eg, viral infection). 34 By analogy, although hypoxia can prime ECs for inflammatory activation, the expression and activity of Cezanne determines whether inflammatory signaling proceeds in response to reoxygenation. Given that Cezanne can be modulated by shear stress, TNFα, interleukin-1, and reactive oxygen species, 15, 16 future studies should address whether these factors influence inflammatory responses to hypoxia-reoxygenation by altering the expression and activity of Cezanne.
We translated our in vitro findings to a murine model by demonstrating that renal inflammation and injury in response to ischemia/reperfusion is enhanced by genetic deletion of Cezanne. Although several articles have studied the function A and B, Expression levels of Cezanne were assessed in left kidneys of male Fisher rats (n=4) that were exposed to ischemia followed by reperfusion. Basal levels of Cezanne were measured in the uninjured right kidney of each animal. A, Cezanne transcript levels were quantified in kidneys exposed to ischemia-reperfusion (6 hours) and uninjured kidneys by real-time polymerase chain reaction (PCR) and normalized by quantifying β-actin transcripts. B, Lysates from kidneys exposed to ischemia-reperfusion (6 hours) or uninjured kidneys were tested by Western blotting using anti-Cezanne antibodies or by using antiα-tubulin antibodies to assess total protein levels. A representative blot and results from densitometry analysis are shown. C and D, Left kidneys of wild-type or Cezanne GT/ GT mice (n=6 per group) were exposed to ischemia followed by reperfusion for 6 hours, whereas contralateral kidneys were uninjured. C, Cezanne transcript levels were quantified in kidneys exposed to ischemia-reperfusion and uninjured kidneys by realtime PCR, and normalized by quantifying β-actin transcripts. D, Cezanne expression was assessed by immunohistochemistry in kidneys exposed to ischemia-reperfusion. Figure 6 . Cezanne reduced inflammation and injury in response to ischemia-reperfusion. Left kidneys of wild-type or Cezanne GT/GT mice (n=6 per group) were exposed to ischemia followed by reperfusion for 6 hours, whereas contralateral kidneys were uninjured. A, Granulocytes were identified by napthol AS-D chloroacetate esterase staining. Representative images are shown, and positive cells are indicated (arrow heads; top). Granulocytes were counted manually, and data were pooled from multiple animals per group (bottom). B, Tissue sections were stained with hematoxylin and eosin before histological assessment. Representative images are shown with areas of acute tubular necrosis (arrows) and hemorrhage (arrow heads) indicated (top). Quantitative assessment of tissue injury was performed by 2 experienced renal researchers, and average scores are shown (bottom). 0 indicates healthy; 1, mild injury; 2, moderate injury; and 3, severe injury.
of Cezanne in cultured cells, this is the first demonstration that Cezanne protects against inflammation and injury in vivo. Because Cezanne was shown to be expressed in renal tissues, but not in peripheral blood, we suggest that local expression of this molecule is responsible for protection. However, we cannot rule out the possibility of systemic effects entirely because a recent study revealed that Cezanne influences B cell function. 17 Immunohistochemistry revealed that Cezanne was expressed in vascular and glomerular ECs in ischemic kidneys as well as in epithelial cells. Thus, the function of Cezanne identified in ischemic kidneys may be attributable, in part, to its induction in ECs in response to hypoxia. The expression of Cezanne in ischemic tissues may also be related to inflammatory cytokines, which are known to induce Cezanne in cultured cells. 15 Future studies using tissue-specific conditional knockout mice should now be performed to define the specific cell populations that are regulated by Cezanne during ischemia. Further studies are also required to examine whether Cezanne is a pleiotropic molecule that possesses divergent functions because baseline phenotyping studies revealed that Cezanne knockout mice have a reduced startle response and lower serum cholesterol levels (http://www.europhenome.org).
Our observation that endogenous Cezanne can reduce inflammation and injury in response to ischemia-reperfusion has important implications for therapeutic targeting of inflammation during transplantation of vascularized organs, bypass grafting, percutaneous coronary intervention of arteries, and other procedures that involve reperfusion. Future studies should examine the potential role of Cezanne induction in ischemic preconditioning, a procedure that is known to protect tissues from subsequent inflammation and injury in response to ischemia-reperfusion. 35 In addition, strategies to enhance Cezanne expression (eg, pharmacologically) in ischemic tissues may inform the development of novel therapies to reduce ischemia-reperfusion injury. GT/GT mice (n=6 per group) were exposed to ischemia followed by reperfusion for 6 hours, whereas contralateral kidneys were uninjured. A, Levels of VCAM-1 or E-selectin transcripts were quantified by real-time polymerase chain reaction. B, Lysates were tested by Western blotting using anti-RelA or anti-Ser536 phosphorylated antibodies or by using anti-GAPDH antibodies to assess total protein levels. Representative blots and results from densitometry analysis are shown.
